Learn More
Medchemexpress LLC 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide | 1012054-59-9 | MFCD15528940 | 99.1% | 434.49 g/mol | C24H26N4O4 | 1 ML

Supplier: Medchemexpress LLC HY1022310MM 1ML
CUDC-101 is a small-molecule inhibitor that targets histone deacetylases (HDAC) and receptor tyrosine kinases EGFR and HER2. It is intended for research use in studies of signaling pathways, anti-proliferative activity, and preclinical cancer models. The compound is supplied as a high-purity reagent suitable for in vitro experiments.
- Multi-target HDAC, EGFR, and HER2 inhibition
- High purity suitable for research applications
- Available as a ready-to-use 10 mM solution in DMSO (1 mL)
- Confirmed molecular formula and molecular weight for analytical workflows
- Intended for in vitro and preclinical research use
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.